835 835 (Galantamine hydrobromide extended release 8 mg)
Pill imprint 835 835 has been identified as Galantamine hydrobromide extended release 8 mg.
Galantamine is used in the treatment of alzheimer's disease and belongs to the drug class cholinesterase inhibitors. Risk cannot be ruled out during pregnancy. Galantamine 8 mg is not a controlled substance under the Controlled Substance Act (CSA).
Galantamine hydrobromide extended release
- Imprint:
- 835 835
- Strength:
- 8 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Cholinesterase inhibitors
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Sun Pharmaceutical Industries Inc.
- National Drug Code (NDC):
- 47335-0835
- Inactive Ingredients:
- corn starch
hypromelloses
hydroxypropyl cellulose
silicon dioxide
magnesium stearate
gelatin
sodium lauryl sulfate
titanium dioxide
More about galantamine
Consumer resources
- Other brands: Razadyne, Razadyne ER
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
